← Eichor
Condition: Immunity Mucosal Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Immunity Mucosal

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Prospective Study for the FOLLOW-UP of Human Monkeypox Cases and Smallpox Vaccinees at Risk
Phase N/A · 1 location(s) · Institute of Tropical Medicine, Belgium · NCT05879965Natural History of Systemic and Nasal Mucosal Immunity to Influenza and SARS-CoV-2 in Adults After Vaccination
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT04794829VRC 900: Evaluation of Tissue-Specific Immune Responses in Adults 18 Years of Age and Older
Phase N/A · 1 location(s) · National Institute of Allergy and Infectious Diseases (NIAID · NCT01132859Viral Mucosal Reprogramming
Phase 2 · 1 location(s) · The University of Texas Medical Branch, Galveston · NCT05331170Oral Bacteria and Immune System Problems Involved in Gum Disease (Periodontitis)
Phase N/A · 1 location(s) · National Institute of Dental and Craniofacial Research (NIDC · NCT01568697Understanding the Determinants of Mucosal Immunity and Optimizing the Diagnosis of Infection With SARS-CoV-2 Variants
NA · 1 location(s) · Institut Pasteur · NCT05858502COMMUNITY - the COVID-19 Immunity Study
Phase N/A · 2 location(s) · Danderyd Hospital · NCT06784739Using Urine to Study Antibodies & Functional Cell-Mediated Immunity in the Context of Chlamydia Trachomatis
Phase N/A · 1 location(s) · Universiteit Antwerpen · NCT07596316Lung Immune Challenge Study: Controlled Exposure to Inhaled Resiquimod (R848)
NA · 1 location(s) · Akhilesh Jha · NCT06488118Characteristics of Immunity in Gut Mucosa, Spinal Fluid, Lymph Node and Blood of HIV Negative Thais and Thais With HIV I
NA · 1 location(s) · SEARCH Research Foundation · NCT01397669Mucosal Associated Invariant T Cell During Viral Pneumonia and Acute Respiratory Distress Syndrome
Phase N/A · 1 location(s) · University Hospital, Tours · NCT06720818A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Select
Phase 1 · 2 location(s) · Kupando GmbH · NCT07600476GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE
NA · 1 location(s) · Imperial College London · NCT06620185Characterizing the Human Airway Immune Response to FluMist Vaccination
Phase 4 · 1 location(s) · Washington University School of Medicine · NCT07177417Neutralizing Power of Serum Antibodies - 2
NA · 1 location(s) · Centre Hospitalier Régional d'Orléans · NCT07085611To Evaluate Mucosal and Systematic Immune Response to Acute Respiratory Tract Infections of South African Children
Phase N/A · 2 location(s) · Desmond Tutu TB Centre · NCT06902194
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.